DEUTSCHE BANK AG\
BankPosition in NBIX — Neurocrine Biosciences Inc
CIK 948046
FRANKFURT AM MAIN, 2M
Position in NBIX
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$48,130,546
-$4,054,948 QoQ
Shares Held
365,345
-0.7% QoQ
Ownership
0.363%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 21.171221721934064.ToString("F0")%
Shared 0.ToString("F0")%
None 78.82877827806594.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026DEUTSCHE BANK AG\ holds $1,164,451,125 across 44 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
5,532,028 | $653,941,023 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
198,777 | $117,870,782 | |
| 3 | VTRS |
Viatris Inc
|
6,512,440 | $87,983,060 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,829,970 | $85,238,695 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
This page
|
365,345 | $48,130,546 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
523,691 | $25,215,720 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
319,675 | $24,583,006 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
236,885 | $17,967,724 |
All Filings in NBIX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $48,130,546 | 365,345 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $52,185,494 | 367,944 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $63,283,863 | 450,804 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $51,530,131 | 409,978 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $47,218,897 | 426,934 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $63,033,241 | 461,782 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $50,446,885 | 437,831 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $59,625,838 | 433,107 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $49,631,336 | 359,856 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $44,413,131 | 337,076 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $31,196,249 | 277,300 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $33,711,211 | 357,489 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $34,435,547 | 340,205 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $81,878,506 | 685,520 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $44,231,682 | 416,455 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $43,615,863 | 447,434 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $38,763,185 | 413,474 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $35,175,462 | 413,003 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $41,208,495 | 429,658 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $41,575,393 | 427,203 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $47,516,930 | 488,606 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $42,086,294 | 439,085 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $48,944,955 | 508,995 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $110,064,008 | 902,164 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $75,492,974 | 872,247 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||